Peru vs Senegal: Share of the population living with HIV receiving antiretroviral therapy
Peru
80.1%
in 2024
Senegal
78.9%
in 2024
Peru rank
52nd
Senegal rank
55th
Share of the population living with HIV receiving antiretroviral therapy over time
- Peru
- Senegal
How they compare
Peru currently reports 80.1% against 78.9% in Senegal, a difference of 1.2%.
The two have swapped places 7 times across 35 shared years of data; in 1990 it was Senegal ahead.
Peru ranks 52nd and Senegal ranks 55th of 149 countries.
Across the 4 decades both report, Peru averaged higher in 2 and Senegal in 1.
Head to head by decade
| Decade | Peru | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | — |
| 2000s | 7.4% | 6.6% | 0.8% | Peru |
| 2010s | 46.6% | 45.5% | 1.1% | Peru |
| 2020s | 74.9% | 76.0% | 1.1% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Peru or Senegal?
- Peru, at 80.1% against 78.9% in Senegal as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Peru and Senegal?
- 1.2%, with Peru ahead.
- How many years of comparable data are there for Peru and Senegal?
- 35 years are reported by both, from 1990 to 2024.
- How do Peru and Senegal rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Peru ranks 52nd and Senegal ranks 55th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.